<?xml version="1.0"?>
<?xml-stylesheet type="text/xsl" href="billres.xsl"?>
<!DOCTYPE bill PUBLIC "-//US Congress//DTDs/bill.dtd//EN" "bill.dtd">
<bill bill-stage="Introduced-in-House" dms-id="HC9BC5B4544B04D358DCFCE97CDFE16CA" public-private="public" bill-type="olc"> 
<metadata xmlns:dc="http://purl.org/dc/elements/1.1/">
<dublinCore>
<dc:title>114 HR 2479 IH: To amend the Federal Food, Drug, and Cosmetic Act to provide for the issuance of up-to-date regulations and guidance applying to the dissemination by means of the Internet of information about medical products.</dc:title>
<dc:publisher>U.S. House of Representatives</dc:publisher>
<dc:date>2015-05-20</dc:date>
<dc:format>text/xml</dc:format>
<dc:language>EN</dc:language>
<dc:rights>Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain.</dc:rights>
</dublinCore>
</metadata>
<form>
<distribution-code display="yes">I</distribution-code> 
<congress>114th CONGRESS</congress>
<session>1st Session</session>
<legis-num>H. R. 2479</legis-num> 
<current-chamber>IN THE HOUSE OF REPRESENTATIVES</current-chamber> 
<action> 
<action-date date="20150520">May 20, 2015</action-date> 
<action-desc><sponsor name-id="L000576">Mr. Long</sponsor> introduced the following bill; which was referred to the <committee-name committee-id="HIF00">Committee on Energy and Commerce</committee-name></action-desc>
</action> 
<legis-type>A BILL</legis-type> 
<official-title>To amend the Federal Food, Drug, and Cosmetic Act to provide for the issuance of up-to-date regulations and guidance applying to the dissemination by means of the Internet of information about medical products.</official-title> 
</form> 
<legis-body id="H998EA491D02043769CA5B5654A6A6A76" style="OLC"> 
<section id="HFDFAD01974D14FD0B2D3C23EB347EE44" section-type="section-one"><enum>1.</enum><header>Dissemination of information about medical products using the Internet</header> 
<subsection id="H3CF377B85EC74C349D0BD762C7187C4E"><enum>(a)</enum><header>In general</header><text>The Federal, Food, Drug, and Cosmetic Act is amended by inserting after section 715 of such Act (<external-xref legal-doc="usc" parsable-cite="usc/21/379d-4">21 U.S.C. 379d–4</external-xref>) the following:</text> <quoted-block id="H67BA51AE0A124754A91C4F16997DCFCD" style="OLC"> <section id="HE99898F4EF274C76AB3DF5724C18E9A4"><enum>716.</enum><header>Dissemination of information about medical products using the Internet</header> <subsection id="H268CF6EE36BB4A779085A86131D321EF"><enum>(a)</enum><header>Proposed revisions</header><text>Not later than 6 months after the date of enactment of this section, the Secretary shall—</text> 
<paragraph id="HC6008F6BECD0425287E3A4E83EB95207"><enum>(1)</enum><text>review each regulation and guidance that applies to the dissemination by means of the Internet (including social media platforms and character-limited applications) of information about medical products; and</text></paragraph> <paragraph id="HC5E8044DB35B4167918AEC6B8B0971D4"><enum>(2)</enum><text>propose revisions to such regulations and guidance (in the form of proposed amended regulations and draft guidance, respectively) that—</text> 
<subparagraph id="H8743282DCCA24F87A3CFFA7EF425917E"><enum>(A)</enum><text>facilitate meaningful use, by the sponsors of medical products, of the Internet, including Internet applications and social media, for dissemination of truthful, non-misleading information about medical products;</text></subparagraph> <subparagraph id="H1FEE1AC8C4E149BE90F16C70E0CABA48"><enum>(B)</enum><text>recognize that such sponsors may use the Internet—</text> 
<clause id="HA2281C220ABA4EDB8989775C7EDAC262"><enum>(i)</enum><text>to disseminate, in character-limited applications, truthful, introductory information about medical products, including the name of such products and their approved uses; and</text></clause> <clause id="HBD0468BD3D5E4C9BA99CDE8643C52FB0"><enum>(ii)</enum><text>to provide additional information about the safety and effectiveness of the medical products using information that is hyperlinked to such introductory information; and</text></clause></subparagraph> 
<subparagraph id="HF6D5713D5207442483EB23734EFB2835"><enum>(C)</enum><text display-inline="yes-display-inline">for regulatory purposes, treat hyperlinked information described in subparagraph (B)(ii) as if the information appeared in introductory information described in subparagraph (B)(i).</text></subparagraph></paragraph></subsection> <subsection id="H74AB4182A01E4805AB6B746C6B4143D1"><enum>(b)</enum><header>Final regulations and guidance; updates</header><text display-inline="yes-display-inline">The Secretary shall, after providing notice and an opportunity for public comment—</text> 
<paragraph id="HBA45603FCD5D439B9C4401D0900E5CE1"><enum>(1)</enum><text>not later than 18 months after publication of proposed regulations and guidance pursuant to subsection (a), publish final regulations and guidance addressing the matters described in subsection (a); and</text></paragraph> <paragraph id="HC161A029F2684E9680E2968EE2DE2442"><enum>(2)</enum><text>periodically thereafter, review and, as appropriate, update such regulations and guidance.</text></paragraph></subsection> 
<subsection id="HA010D9534441441A9D48A86C2CF737BF"><enum>(c)</enum><header>Medical product defined</header><text>In this section, the term <quote>medical product</quote> means a drug, biological product, or device. </text></subsection></section><after-quoted-block>.</after-quoted-block></quoted-block></subsection> <subsection id="HFCE2FF9A98B24BEF91D32AF7E61B6DE9"><enum>(b)</enum><header>Conforming repeal</header><text>Section 1121 of the Food and Drug Administration Safety and Innovation Act (<external-xref legal-doc="public-law" parsable-cite="pl/112/144">Public Law 112–144</external-xref>; <external-xref legal-doc="usc" parsable-cite="usc/21/379d-5">21 U.S.C. 379d–5</external-xref>) is repealed.</text></subsection></section> 
</legis-body> 
</bill> 

